Xtant Medical Holdings, Inc. financial data

Symbol
XTNT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
664 Cruiser Lane, Belgrade, Montana
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Bacterin International Holdings, Inc. (to 8/3/2015), K KITZ INC (to 5/21/2010)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 260 % -16.4%
Quick Ratio 144 % +16%
Debt-to-equity 86.2 % +5.34%
Return On Equity -3.6 % +86.2%
Return On Assets -1.93 % +86.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 130M shares +19.6%
Common Stock, Shares, Outstanding 130M shares +19.6%
Entity Public Float 25.8M USD +269%
Weighted Average Number of Shares Outstanding, Basic 130M shares +19.6%
Weighted Average Number of Shares Outstanding, Diluted 130M shares +19.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 101M USD +60.8%
Research and Development Expense 1.69M USD +92.8%
Selling and Marketing Expense 43.8M USD +80%
General and Administrative Expense 28.8M USD +75.6%
Operating Income (Loss) -12.1M USD -85.4%
Nonoperating Income (Expense) 8.75M USD -76.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.3M USD +60.2%
Income Tax Expense (Benefit) -1.64M USD -2883%
Net Income (Loss) Attributable to Parent -1.66M USD +80.1%
Earnings Per Share, Basic 0 USD/shares -50%
Earnings Per Share, Diluted 0 USD/shares -50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.55M USD -12.2%
Accounts Receivable, after Allowance for Credit Loss, Current 21.5M USD +80.5%
Inventory, Net 38.7M USD +109%
Assets, Current 66.5M USD +81.9%
Property, Plant and Equipment, Net 8.87M USD +29.9%
Operating Lease, Right-of-Use Asset 1.44M USD +13.2%
Intangible Assets, Net (Excluding Goodwill) 9.65M USD -10.7%
Goodwill 7.3M USD -4.41%
Other Assets, Noncurrent 132K USD -28.6%
Assets 93.9M USD +48.4%
Accounts Payable, Current 7.38M USD +116%
Accrued Liabilities, Current 9.88M USD +76.5%
Liabilities, Current 28.4M USD +64.6%
Deferred Income Tax Liabilities, Net 21K USD
Operating Lease, Liability, Noncurrent 644K USD -24%
Other Liabilities, Noncurrent 240K USD
Liabilities 46.3M USD +51.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -133K USD
Retained Earnings (Accumulated Deficit) -247M USD -0.68%
Stockholders' Equity Attributable to Parent 47.7M USD +45.8%
Liabilities and Equity 93.9M USD +48.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.76M USD -156%
Net Cash Provided by (Used in) Financing Activities 5.18M USD +13.4%
Net Cash Provided by (Used in) Investing Activities -674K USD +96.1%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 130M shares +19.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.3M USD +91.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.62M USD -14.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 740K USD +45.4%
Deferred Tax Assets, Valuation Allowance 25.8M USD +24%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 26.6M USD +24.9%
Operating Lease, Liability 1.59M USD +11.1%
Depreciation 2.1M USD +75%
Payments to Acquire Property, Plant, and Equipment 773K USD +69.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.56M USD -120%
Lessee, Operating Lease, Liability, to be Paid 1.72M USD +9.85%
Property, Plant and Equipment, Gross 29.4M USD +17.3%
Operating Lease, Liability, Current 853K USD +80.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 680K USD +21.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 918K USD +71.9%
Deferred Income Tax Expense (Benefit) -1.9M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 128K USD -3.76%
Lessee, Operating Lease, Liability, to be Paid, Year Three 119K USD -74.7%
Deferred Tax Assets, Operating Loss Carryforwards 18.6M USD +35.7%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -1.42M USD
Current Income Tax Expense (Benefit) 204K USD +196%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 295M USD +6.02%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 93K USD +34.8%
Amortization of Intangible Assets 400K USD +300%
Depreciation, Depletion and Amortization 1.01M USD +113%
Deferred State and Local Income Tax Expense (Benefit) -479K USD
Interest Expense 3.2M USD +67.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%